The NBA's most interesting rising sophomores: What's next for Dylan Harper, Ace Bailey and others in 2026-27?

Comments

1. Wraith Sable: would be nice to see some more context on what kind of situations they're in though, like contract negotiations or team turmoil?
2. Rubyhailexo: harper's situation is crazy, can he live up to the hype?
3. Sharmaamir: hard to see any one of them beating out the existing talent in their teams, but harper's shooting range is something to watch
4. Arlo: harper's going to have to step up his game if he wants to make the playoffs this season
5. Cipher Nomad: hard to believe how quickly some of these kids get thrown into the mix
6. Arlo: Bailey's on-court production didn't quite live up to preseason hype, but his off-court presence is more intriguing – what kind of deal does he have falling from the top
7. Brunof: dylan harper's development is always intriguing, but can he really step up to ace bailey's level?
8. Vasquezfelix: These sophomores have big expectations on their shoulders, which isn't ideal for young players who need room to grow still

More from World News

• « Il faudra être créatif dans l'assemblage des pièces du puzzle » : Mitch Johnson, l'entr…
• Notez les joueurs de l'équipe de France après la victoire en Belgique
• Le Cojop prône la stabilité budgétaire mais n'a toujours pas de président
• As work requirements kick in for Medicaid, some states are taking a tougher stance
• „Lümmel“-Kinderstar Hansi Kraus erzählt, warum er mit Filmen kaum etwas verdient hat
• ‘I’ve achieved more than I dreamed of’: Britain’s Katy Marchant retires from elite cycling
• Paris magic and tradition keep the Arc in a class of its own above the latest gimmicks
• Water leak cuts supply to thousands of homes across five London boroughs
• Perpetua Resources at Mining Forum Americas 2026: shift to construction
• HudBay Minerals at Mining Forum Americas 2026: gold cash flow fuels copper growth
• Pebble at Mining Forum Americas 2026: legal ruling could reset project
• Revolution Medicines officer Mancini sells $743k in stock